INVO Fertility, Inc. Finance Lease, Right-of-Use Asset, Amortization
INVO Fertility, Inc. (IVF) reported Finance Lease, Right-of-Use Asset, Amortization of $63.05 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FinanceLeaseRightOfUseAssetAmortization · last filed 2021-11-15
- INVO Fertility, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-09-30 was $28.70K, a 392.06% increase year-over-year.
- INVO Fertility, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-06-30 was $28.68K, a 414.90% increase year-over-year.
- INVO Fertility, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2021-03-31 was $5.67K, a 2.64% increase year-over-year.
- INVO Fertility, Inc. finance lease, right-of-use asset, amortization for the quarter ending 2020-12-31 was $5.63K, a 2.60% increase year-over-year.
- INVO Fertility, Inc. finance lease, right-of-use asset, amortization for fiscal 2020 was $22.56K, a 54.99% increase from fiscal 2019.
- INVO Fertility, Inc. finance lease, right-of-use asset, amortization for fiscal 2019 was $14.56K.
- INVO Fertility, Inc. finance lease, right-of-use asset, amortization for fiscal 2018 was $0.00.
| Period end | Finance Lease, Right-of-Use Asset, Amortization 3 month | Finance Lease, Right-of-Use Asset, Amortization 6 month | Finance Lease, Right-of-Use Asset, Amortization 9 month | Finance Lease, Right-of-Use Asset, Amortization 12 month |
|---|---|---|---|---|
| 2021-09-30 | $28.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $57.37K derived: sum of 2 quarters · filed 2021-11-15 | $63.05K 10-Q · filed 2021-11-15 | $68.68K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | $28.68K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $34.35K 10-Q · filed 2021-08-16 | $39.98K derived: sum of 3 quarters · filed 2021-08-16 | $45.82K derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-03-31 | $5.67K 10-Q · filed 2021-05-17 | $11.31K derived: sum of 2 quarters · filed 2021-05-17 | $17.14K derived: sum of 3 quarters · filed 2021-11-15 | $22.71K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-12-31 | $5.63K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $11.47K derived: sum of 2 quarters · filed 2021-11-15 | $17.04K derived: sum of 3 quarters · filed 2021-11-15 | $22.56K 10-K · filed 2021-03-30 |
| 2020-09-30 | $5.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $11.40K derived: sum of 2 quarters · filed 2021-11-15 | $16.93K 10-Q · filed 2021-11-15 | $22.42K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $5.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $11.10K 10-Q · filed 2021-08-16 | $16.59K derived: sum of 3 quarters · filed 2021-08-16 | $22.04K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $5.53K 10-Q · filed 2021-05-17 | $11.02K derived: sum of 2 quarters · filed 2021-05-17 | $16.47K derived: sum of 3 quarters · filed 2021-05-17 | $20.09K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $5.49K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $10.94K derived: sum of 2 quarters · filed 2021-03-30 | $14.56K derived: sum of 3 quarters · filed 2021-03-30 | $14.56K 10-K · filed 2021-03-30 |
| 2019-09-30 | $5.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $9.07K derived: sum of 2 quarters · filed 2020-11-16 | $9.07K 10-Q · filed 2020-11-16 | $9.07K derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $3.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $3.61K 10-Q · filed 2020-08-13 | $3.61K derived: sum of 3 quarters · filed 2020-08-13 | $3.61K derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | $0.00 derived: sum of 2 quarters · filed 2020-05-15 | $0.00 derived: sum of 3 quarters · filed 2020-05-15 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |